Evidence map›Paper›PMID 30992346›Full record

ArticleJournal of cell science2019

Sina Krokowski, Sharanjeet Atwal, Damián Lobato-Márquez, Arnaud Chastanet, Rut Carballido-López, Jeanne Salje, Serge Mostowy

Open access · hybridAbstract read
In one paragraph

Article in Journal of cell science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 4 countries.

Sina KrokowskiSection of Microbiology, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, Armstrong Road, London SW7 2AZ, UK.
Sharanjeet AtwalCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7JT, UK.
Damián Lobato-MárquezSection of Microbiology, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, Armstrong Road, London SW7 2AZ, UK.
Arnaud ChastanetMICALIS Institute, INRA, AgroParisTech, Université Paris-Saclay, 78350 Jouy-en-Josas, France.
Rut Carballido-LópezMICALIS Institute, INRA, AgroParisTech, Université Paris-Saclay, 78350 Jouy-en-Josas, France.
Jeanne SaljeCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7JT, UK.ORCID 0000-0001-5802-4580
Serge MostowySection of Microbiology, MRC Centre for Molecular Bacteriology and Infection, Imperial College London, Armstrong Road, London SW7 2AZ, UK serge.mostowy@lshtm.ac.uk.ORCID 0000-0002-7286-6503
University of London · GBAgroParisTech · FRRutgers, The State University of New Jersey · US

Funding

Wellcome Trust 206444/Z/17/ZWellcome Trust WT097411MA
6 · The paper itself

Abstract

Pathogenic

Indexed as

Shigella flexneriActin CytoskeletonActinsBacterial ProteinsDNA-Binding ProteinsEscherichia coli ProteinsHeLa CellsHost Microbial InteractionsHumansTranscription FactorsActinsBacterial ProteinsDNA-Binding ProteinsEscherichia coli ProteinsMreB protein, E coliTranscription FactorsvirG protein, Shigella flexneriActinIcsAMreBSeptinShigella

Identifiers

PMID30992346
PMCPMC6526709
OpenAlexW2936281762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.